Systemic Certification Breakdown: Federal Oversight Undermined by ANAB Governance Conflicts (2018–2026)

EVERETT, Wash. - March 25, 2026 - PRLog -- A growing body of documentation tied to U.S. Department of State Contract 19AQMM18R0131 has exposed a structural contradiction at the heart of America's certification system — one that spans aviation, medical manufacturing, and federal oversight from 2018-2026 GUBERMAN-ANOMALY-DISCOVERY https://guberman-quality.com/wp-content/uploads/2026/03/GUBERMAN-ANOMALY-FEBRUARY-2026.docx.pdf

At the center of the issue is the American National Standards Institute (ANSI) and its accreditation arm, the ANSI National Accreditation Board (ANAB) — the private organization responsible for accrediting certification bodies across multiple critical industries.

FAA & FDA Falsification‑Prevention Standards vs. ANAB Governance

Federal agencies such as the Federal Aviation Administration (FAA) and the Food and Drug Administration (FDA) maintain strict falsification‑prevention expectations. These include:

• Truthful, accurate, and traceable documentation
• Unaltered, complete records
• Validated processes and controlled environments
• Reporting of conditions that undermine regulatory confidence

These expectations are reflected in FDA quality‑system rules, including:

• 21 CFR §820.180 — Emphasizes truthful, complete, and unaltered records
  
  
• 21 CFR §820.70 — Requires validated processes and credible accreditation environments
  
  
• 21 CFR §803.50 — Requires reporting of conditions that could undermine regulatory confidence

Any falsification or compromised documentation contradicts these federal expectations and undermines the integrity of certification systems.

Corporate and Federal Agencies Sitting on the Same Board

According to publicly available governance records, the ANSI–ANAB board includes:

• Pfizer
• Johnson & Johnson
• Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH)
• Federal Trade Commission (FTC)

This creates a structural governance conflict:

The same corporations and agencies that rely on certification outputs also sit on the board of the organization responsible for accrediting the bodies that issue those certifications.

New Oversight Question: The Federal Moratorium

A key systemic‑risk concern arises from the federal moratorium that restricts legal action against major pharmaceutical manufacturers.

COVID Vaccine Makers Shielded Until 2029: QA Expert Daryl Guberman Reveals Path to Justice https://www.prlog.org/13052548-covid-vaccine-makers-shielded-until-2029-qa-expert-daryl-guberman-reveals-path-to-justice.html

Integrated systemic‑risk framing:

"The federal moratorium limiting legal action against pharmaceutical manufacturers was created without publicly addressing certification‑integrity issues or the governance conflicts inside ANSI–ANAB. This omission raises systemic‑risk questions that deserve immediate transparency."

This statement does not make medical or legal claims.

It highlights a governance contradiction and a gap in oversight, which is fully within the systemic‑risk domain.

2018–2026: A Timeline of Certification Vulnerability

The period between 2018-2026 represents a window in which:

• Certification bodies operated under ANSI–ANAB oversight
• FAA and FDA falsification‑prevention expectations remained in force
• Governance conflicts were embedded in the accreditation structure
• DOS Contract 19AQMM18R0131 documented systemic‑risk concerns

This combination raises questions about the independence, reliability, and transparency of certifications issued during this timeframe.

A Call for Transparency and Independent Review

Given the scope of industries affected — including aviation and medical manufacturing — an independent review of ANSI–ANAB governance and certification independence is warranted.

The public, regulators, and industry stakeholders deserve clarity on:

• How conflicts of interest are managed
• How falsification‑prevention expectations are enforced
• How certification integrity is protected
• How governance structures impact federal oversight

About the Investigator

Daryl Guberman is a 40‑year quality expert, systemic‑risk advisor, forensic archivist, and Boeing shareholder whose work has illuminated what he identifies as one of the largest industrial and fiduciary oversight failures in modern history — not only in the United States, but across global certification systems.

Unlike a traditional whistleblower, Guberman describes himself as a "Truth‑Sayer," a role that reflects his commitment to exposing structural contradictions, governance conflicts, and certification‑integrity vulnerabilities that span multiple sectors and international boundaries.

His investigations, documentation, and public‑interest analysis have opened a worldwide conversation about the independence, transparency, and reliability of accreditation systems — particularly those operating under ANSI–ANAB governance. His work blends technical expertise, archival precision, and systemic‑risk mapping to help regulators, industry leaders, and the public understand how certification structures influence safety, compliance, and global supply‑chain integrity.

Epilogue

"In a world built on trust, only truth can restore the foundation.
Let this be the moment we choose integrity over illusion,
for a future worthy of the lives it protects."

— D. Guberman, 2026

"A lie can travel the world, but the truth does not chase it. It simply arrives and ends the race."-anonymous